75617 A 12-week real-world evaluation of safety and efficacy of trifarotene treatment for facial and truncal acne in Indian subjects
Journal of the American Academy of Dermatology · 2026-07 · 95 (1) · AB10
DOI: 10.1016/j.jaad.2026.04.059 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Academy of Dermatology, 2026-07. Verfasst von B.S. Chandrashekar und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Chandrashekar, B., Tahiliani, S., De, A., & Sen, D. (2026). 75617 A 12-week real-world evaluation of safety and efficacy of trifarotene treatment for facial and truncal acne in Indian subjects. Journal of the American Academy of Dermatology, 95(1), AB10. https://doi.org/10.1016/j.jaad.2026.04.059
Vancouver
Chandrashekar B, Tahiliani S, De A, Sen D. 75617 A 12-week real-world evaluation of safety and efficacy of trifarotene treatment for facial and truncal acne in Indian subjects. Journal of the American Academy of Dermatology. 2026;95(1):AB10. doi:10.1016/j.jaad.2026.04.059
BibTeX
@article{Chandrashekar2026,
author = {Chandrashekar, B.S. and Tahiliani, Sushil and De, Abhishek and Sen, Dyotona},
title = {75617 A 12-week real-world evaluation of safety and efficacy of trifarotene treatment for facial and truncal acne in Indian subjects},
journal = {Journal of the American Academy of Dermatology},
year = {2026},
volume = {95},
number = {1},
pages = {AB10},
doi = {10.1016/j.jaad.2026.04.059}
}
EUVIMED